Shannon L. Werner

2.4k total citations
21 papers, 1.9k citations indexed

About

Shannon L. Werner is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Shannon L. Werner has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Shannon L. Werner's work include NF-κB Signaling Pathways (8 papers), Immune Response and Inflammation (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Shannon L. Werner is often cited by papers focused on NF-κB Signaling Pathways (8 papers), Immune Response and Inflammation (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Shannon L. Werner collaborates with scholars based in United States and South Korea. Shannon L. Werner's co-authors include Alexander Hoffmann, Derren Barken, Jeffrey D. Kearns, Soumen Basak, Ellen L O'Dea, Christine Huang, Andre Levchenko, Gourisankar Ghosh, Carl F. Ware and Hana Kim and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Shannon L. Werner

20 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon L. Werner United States	13	909	897	886	498	97	21	1.9k
Christos Patriotis United States	22	1.1k 1.2×	647 0.7×	634 0.7×	490 1.0×	86 0.9×	44	2.1k
Jeffrey D. Kearns United States	18	725 0.8×	818 0.9×	920 1.0×	506 1.0×	66 0.7×	33	1.6k
Yao-Chen Tsui United States	9	827 0.9×	670 0.7×	1.0k 1.1×	593 1.2×	114 1.2×	10	2.0k
Manuel Izquierdo Spain	28	1.4k 1.5×	374 0.4×	932 1.1×	357 0.7×	71 0.7×	61	2.2k
Jin‐Ku Lee South Korea	20	903 1.0×	455 0.5×	268 0.3×	467 0.9×	160 1.6×	34	1.7k
Amy Clem United States	18	1.3k 1.4×	1.0k 1.2×	298 0.3×	412 0.8×	84 0.9×	23	1.9k
Jena M. Giltnane United States	9	1.1k 1.2×	240 0.3×	1.1k 1.2×	612 1.2×	77 0.8×	10	2.4k
Ethan Emberley Canada	19	1.1k 1.2×	442 0.5×	297 0.3×	261 0.5×	129 1.3×	28	1.4k
Hans-Guido Wendel United States	14	2.1k 2.3×	380 0.4×	294 0.3×	542 1.1×	111 1.1×	20	2.5k
Qi‐En Wang United States	29	1.8k 1.9×	447 0.5×	320 0.4×	777 1.6×	125 1.3×	65	2.4k

Countries citing papers authored by Shannon L. Werner

Since Specialization

Citations

This map shows the geographic impact of Shannon L. Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon L. Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon L. Werner more than expected).

Fields of papers citing papers by Shannon L. Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon L. Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon L. Werner. The network helps show where Shannon L. Werner may publish in the future.

Co-authorship network of co-authors of Shannon L. Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon L. Werner. A scholar is included among the top collaborators of Shannon L. Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon L. Werner. Shannon L. Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Werner, Shannon L., et al.. (2021). Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability. Journal of Managed Care & Specialty Pharmacy. 27(4). 488–496.

2.

Szabó, Anikó, et al.. (2018). Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients. Journal of the American Pharmacists Association. 59(1). 51–56. 8 indexed citations

3.

Yarur, Andrés, Anjali Jain, Venkateswarlu Kondragunta, et al.. (2017). Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab. Gastroenterology. 152(5). S389–S389. 6 indexed citations

4.

Werner, Shannon L., et al.. (2017). Accelerated Dosing of Infliximab Is Not Associated With Improved Colectomy Rates in Hospitalized Severe Ulcerative Colitis Patients. The American Journal of Gastroenterology. 112. S382–S383. 5 indexed citations

5.

Greene, Stephanie, Angel E. Dago, Yipeng Wang, et al.. (2016). Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis. PLoS ONE. 11(11). e0165089–e0165089. 37 indexed citations

6.

Jia, Shidong, Sarah K. Baird, Amanda Anderson, et al.. (2016). Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 34(2_suppl). 195–195. 1 indexed citations

7.

Kearns, Jeffrey D., Raghida A. Bukhalid, Mark Sevecka, et al.. (2015). Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic. Molecular Cancer Therapeutics. 14(7). 1625–1636. 46 indexed citations

8.

Werner, Shannon L., Ryon P. Graf, Mark Landers, et al.. (2015). Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization. 4(1). 8 indexed citations

9.

Werner, Shannon L., Ryon P. Graf, Mark Landers, et al.. (2015). Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization. SHILAP Revista de lepidopterología. 4. 3–3. 100 indexed citations

10.

Graf, Ryon P., David T. Valenta, Mark Landers, et al.. (2015). Abstract 1584: Analytical and clinical validation of the Epic Circulating Tumor Cell (CTC) Platform: enrichment-free CTC detection and biomarker characterization. Cancer Research. 75(15_Supplement). 1584–1584. 2 indexed citations

11.

Behar, Marcelo, Derren Barken, Shannon L. Werner, & Alexander Hoffmann. (2013). The Dynamics of Signaling as a Pharmacological Target. Cell. 155(2). 448–461. 104 indexed citations

12.

Kearns, Jeffrey D., Neeraj Kohli, Shannon L. Werner, et al.. (2011). Abstract A210: Mechanism of action of MM-151, a potent mixture of three human antibody antagonists targeting EGFR.. Molecular Cancer Therapeutics. 10(11_Supplement). A210–A210. 2 indexed citations

13.

Song, Eun Joo, Shannon L. Werner, Frank Stegmeier, et al.. (2010). The Prp19 complex and the Usp4^Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes & Development. 24(13). 1434–1447. 183 indexed citations

14.

Werner, Shannon L., Jeffrey D. Kearns, Candace Lynch, et al.. (2008). Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20. Genes & Development. 22(15). 2093–2101. 173 indexed citations

15.

Basak, Soumen, Hana Kim, Jeffrey D. Kearns, et al.. (2007). A Fourth IκB Protein within the NF-κB Signaling Module. Cell. 128(2). 369–381. 310 indexed citations

16.

Basak, Soumen, Hana Kim, Jeffrey D. Kearns, et al.. (2007). A Fourth IkB Protein within the NF-kB Signaling Module. 16 indexed citations

17.

Kearns, Jeffrey D., Soumen Basak, Shannon L. Werner, Christine Huang, & Alexander Hoffmann. (2006). IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression. The Journal of Cell Biology. 173(5). 659–664. 187 indexed citations

18.

Werner, Shannon L., Derren Barken, & Alexander Hoffmann. (2005). Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity. Science. 309(5742). 1857–1861. 414 indexed citations

19.

Cheong, Raymond, et al.. (2005). Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses. Journal of Biological Chemistry. 281(5). 2945–2950. 105 indexed citations

20.

Werner, Shannon L., et al.. (1974). Primary hyperparathyroidism. Analysis of findings in a series of 129 patients.. PubMed. 140(8). 618–25. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact